Cargando…

Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research

SIMPLE SUMMARY: In 2020, Slovenia joined the global effort to develop effective vaccines and drugs to treat COVID-19. Two vaccine candidates developed in previous studies were selected and tested in the golden hamster model using four different vaccination protocols. We followed the required 3Rs pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Štrbenc, Malan, Kuhar, Urška, Lainšček, Duško, Orehek, Sara, Slavec, Brigita, Krapež, Uroš, Malovrh, Tadej, Majdič, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451472/
https://www.ncbi.nlm.nih.gov/pubmed/37627407
http://dx.doi.org/10.3390/ani13162616
_version_ 1785095422915641344
author Štrbenc, Malan
Kuhar, Urška
Lainšček, Duško
Orehek, Sara
Slavec, Brigita
Krapež, Uroš
Malovrh, Tadej
Majdič, Gregor
author_facet Štrbenc, Malan
Kuhar, Urška
Lainšček, Duško
Orehek, Sara
Slavec, Brigita
Krapež, Uroš
Malovrh, Tadej
Majdič, Gregor
author_sort Štrbenc, Malan
collection PubMed
description SIMPLE SUMMARY: In 2020, Slovenia joined the global effort to develop effective vaccines and drugs to treat COVID-19. Two vaccine candidates developed in previous studies were selected and tested in the golden hamster model using four different vaccination protocols. We followed the required 3Rs principle when performing the procedures on the animals: we refined animal housing, handling, and measurements, including the introduction of pilot animal infection tests, and we reduced the total number of animals used primarily through the replacement procedure. Replacement was conducted by using a virus neutralisation test on cell cultures prior to infecting and killing the animals. We determined that the antibodies produced by the tested vaccines did not have sufficient neutralising properties, and the project was terminated. Approximately half of the golden hamsters that were no longer needed in the procedures were rehomed and we received very encouraging feedback from adopters. ABSTRACT: Effective vaccines are needed to fight the COVID-19 pandemic. Forty golden hamsters were inoculated with two promising vaccine candidates and eighteen animals were used in pilot trials with viral challenge. ELISA assays were performed to determine endpoint serum titres for specific antibodies and virus neutralisation tests were used to evaluate the efficacy of antibodies. All tests with serum from vaccinated hamsters were negative even after booster vaccinations and changes in vaccination protocol. We concluded that antibodies did not have sufficient neutralising properties. Refinements were observed at all steps, and the in vitro method (virus neutralisation test) presented a replacement measure and ultimately lead to a reduction in the total number of animals used in the project. The institutional animal welfare officer and institutional designated veterinarian approved the reuse or rehoming of the surplus animals. Simple socialization procedures were performed and ultimately 19 animals were rehomed, and feedback was collected. Recently, FELASA published recommendations for rehoming of animals used for scientific and educational purposes, with species-specific guidelines, including mice, rats, and rabbits. Based on our positive experience and feedback from adopters, we concluded that the rehoming of rodents, including hamsters, is not only possible, but highly recommended.
format Online
Article
Text
id pubmed-10451472
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104514722023-08-26 Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research Štrbenc, Malan Kuhar, Urška Lainšček, Duško Orehek, Sara Slavec, Brigita Krapež, Uroš Malovrh, Tadej Majdič, Gregor Animals (Basel) Article SIMPLE SUMMARY: In 2020, Slovenia joined the global effort to develop effective vaccines and drugs to treat COVID-19. Two vaccine candidates developed in previous studies were selected and tested in the golden hamster model using four different vaccination protocols. We followed the required 3Rs principle when performing the procedures on the animals: we refined animal housing, handling, and measurements, including the introduction of pilot animal infection tests, and we reduced the total number of animals used primarily through the replacement procedure. Replacement was conducted by using a virus neutralisation test on cell cultures prior to infecting and killing the animals. We determined that the antibodies produced by the tested vaccines did not have sufficient neutralising properties, and the project was terminated. Approximately half of the golden hamsters that were no longer needed in the procedures were rehomed and we received very encouraging feedback from adopters. ABSTRACT: Effective vaccines are needed to fight the COVID-19 pandemic. Forty golden hamsters were inoculated with two promising vaccine candidates and eighteen animals were used in pilot trials with viral challenge. ELISA assays were performed to determine endpoint serum titres for specific antibodies and virus neutralisation tests were used to evaluate the efficacy of antibodies. All tests with serum from vaccinated hamsters were negative even after booster vaccinations and changes in vaccination protocol. We concluded that antibodies did not have sufficient neutralising properties. Refinements were observed at all steps, and the in vitro method (virus neutralisation test) presented a replacement measure and ultimately lead to a reduction in the total number of animals used in the project. The institutional animal welfare officer and institutional designated veterinarian approved the reuse or rehoming of the surplus animals. Simple socialization procedures were performed and ultimately 19 animals were rehomed, and feedback was collected. Recently, FELASA published recommendations for rehoming of animals used for scientific and educational purposes, with species-specific guidelines, including mice, rats, and rabbits. Based on our positive experience and feedback from adopters, we concluded that the rehoming of rodents, including hamsters, is not only possible, but highly recommended. MDPI 2023-08-14 /pmc/articles/PMC10451472/ /pubmed/37627407 http://dx.doi.org/10.3390/ani13162616 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Štrbenc, Malan
Kuhar, Urška
Lainšček, Duško
Orehek, Sara
Slavec, Brigita
Krapež, Uroš
Malovrh, Tadej
Majdič, Gregor
Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research
title Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research
title_full Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research
title_fullStr Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research
title_full_unstemmed Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research
title_short Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research
title_sort rehoming and other refinements and replacement in procedures using golden hamsters in sars-cov-2 vaccine research
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451472/
https://www.ncbi.nlm.nih.gov/pubmed/37627407
http://dx.doi.org/10.3390/ani13162616
work_keys_str_mv AT strbencmalan rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch
AT kuharurska rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch
AT lainscekdusko rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch
AT oreheksara rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch
AT slavecbrigita rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch
AT krapezuros rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch
AT malovrhtadej rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch
AT majdicgregor rehomingandotherrefinementsandreplacementinproceduresusinggoldenhamstersinsarscov2vaccineresearch